Thumbnail website _ 1200x675_Glaukos Submits FDA New Drug Application for Non Invasive Keratoconus Treatment
December 24, 2024

Glaukos Submits NDA for Non-Invasive Keratoconus Treatment

The candidate for FDA approval is an epi-on evolution of their previous iLink procedure. Glaukos Corporation (California, USA) has announced…

Thumbnail_Article Day 3 11
August 8, 2024

Winning the Keratoconus Battle: Strategies and Goals in Managing Corneal Issues in Children

Pediatric keratoconus presents unique challenges, often being more aggressive and difficult to diagnose compared to adult cases, leading to delays…

Discover our fascinating content at issuu

explore